UA77644C2 - Use of inhibitors of dipeptidyl peptidase iv in treatment of infertility - Google Patents

Use of inhibitors of dipeptidyl peptidase iv in treatment of infertility Download PDF

Info

Publication number
UA77644C2
UA77644C2 UA2001096488A UA2001096488A UA77644C2 UA 77644 C2 UA77644 C2 UA 77644C2 UA 2001096488 A UA2001096488 A UA 2001096488A UA 2001096488 A UA2001096488 A UA 2001096488A UA 77644 C2 UA77644 C2 UA 77644C2
Authority
UA
Ukraine
Prior art keywords
inhibitors
infertility
pharmaceutical composition
treatment
dipeptidyl peptidase
Prior art date
Application number
UA2001096488A
Other languages
English (en)
Ukrainian (uk)
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of UA77644C2 publication Critical patent/UA77644C2/uk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
UA2001096488A 1999-03-23 2000-03-21 Use of inhibitors of dipeptidyl peptidase iv in treatment of infertility UA77644C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9906714.2A GB9906714D0 (en) 1999-03-23 1999-03-23 Compositions for improving fertility
PCT/IB2000/000382 WO2000056296A2 (en) 1999-03-23 2000-03-21 Compositions for improving fertility

Publications (1)

Publication Number Publication Date
UA77644C2 true UA77644C2 (en) 2007-01-15

Family

ID=10850229

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2001096488A UA77644C2 (en) 1999-03-23 2000-03-21 Use of inhibitors of dipeptidyl peptidase iv in treatment of infertility

Country Status (29)

Country Link
US (1) US7115650B1 (ko)
EP (1) EP1162969B1 (ko)
JP (1) JP2002539243A (ko)
KR (1) KR100689951B1 (ko)
CN (1) CN1196483C (ko)
AR (1) AR023129A1 (ko)
AT (1) ATE328594T1 (ko)
AU (1) AU765912B2 (ko)
CA (1) CA2366911C (ko)
CZ (1) CZ20013410A3 (ko)
DE (1) DE60028552T2 (ko)
DK (1) DK1162969T3 (ko)
ES (1) ES2265918T3 (ko)
GB (1) GB9906714D0 (ko)
HK (1) HK1046647B (ko)
HU (1) HUP0200410A3 (ko)
IL (1) IL145569A0 (ko)
MX (1) MXPA01009612A (ko)
MY (1) MY135683A (ko)
NO (1) NO20014607L (ko)
NZ (1) NZ514449A (ko)
PL (1) PL195779B1 (ko)
PT (1) PT1162969E (ko)
RU (1) RU2246944C2 (ko)
TR (1) TR200102647T2 (ko)
TW (1) TWI244920B (ko)
UA (1) UA77644C2 (ko)
WO (1) WO2000056296A2 (ko)
ZA (1) ZA200108083B (ko)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6979697B1 (en) 1998-08-21 2005-12-27 Point Therapeutics, Inc. Regulation of substrate activity
GB9928330D0 (en) * 1999-11-30 2000-01-26 Ferring Bv Novel antidiabetic agents
US6395767B2 (en) 2000-03-10 2002-05-28 Bristol-Myers Squibb Company Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
WO2002072582A1 (en) 2001-03-12 2002-09-19 Ortho-Mcneil Pharmaceutical, Inc. Methods for the synthesis of densely functionalized pyrrolidine template libraries
GB0109146D0 (en) * 2001-04-11 2001-05-30 Ferring Bv Treatment of type 2 diabetes
ES2296962T3 (es) 2001-06-27 2008-05-01 Smithkline Beecham Corporation Pirrolidinas como inhibidores de dipeptidil peptidasa.
KR20040015298A (ko) 2001-06-27 2004-02-18 스미스클라인 비참 코포레이션 디펩티딜 펩티다제 억제제로서의 플루오로피롤리딘
EP1399433B1 (en) 2001-06-27 2007-08-22 Smithkline Beecham Corporation Fluoropyrrolidines as dipeptidyl peptidase inhibitors
DE60304911D1 (de) 2002-02-25 2006-06-08 Eisai Co Ltd Xanthin-Derivate als DPP-IV-Inhibitoren
US6710040B1 (en) 2002-06-04 2004-03-23 Pfizer Inc. Fluorinated cyclic amides as dipeptidyl peptidase IV inhibitors
TWI273104B (en) 2002-06-06 2007-02-11 Eisai Co Ltd Novel fused imidazole derivative
WO2005026114A1 (en) * 2003-09-17 2005-03-24 Pfizer Inc. Hiv protease inhibitors, compositions containing the same and their pharmaceutical uses
DOP2006000008A (es) 2005-01-10 2006-08-31 Arena Pharm Inc Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
DK1942898T4 (da) 2005-09-14 2014-06-02 Takeda Pharmaceutical Dipeptidylpeptidase-inhibitorer til behandling af diabetes
KR101368988B1 (ko) 2005-09-16 2014-02-28 다케다 야쿠힌 고교 가부시키가이샤 디펩티딜 펩티다제 억제제
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
PE20071221A1 (es) 2006-04-11 2007-12-14 Arena Pharm Inc Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
US8324383B2 (en) 2006-09-13 2012-12-04 Takeda Pharmaceutical Company Limited Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
US8093236B2 (en) 2007-03-13 2012-01-10 Takeda Pharmaceuticals Company Limited Weekly administration of dipeptidyl peptidase inhibitors
US8247438B2 (en) 2008-02-27 2012-08-21 Neuropill, Inc. Methods for treating schizophrenia
EP2146210A1 (en) 2008-04-07 2010-01-20 Arena Pharmaceuticals, Inc. Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY
AR077642A1 (es) 2009-07-09 2011-09-14 Arena Pharm Inc Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
CN102918027A (zh) 2010-04-06 2013-02-06 艾尼纳制药公司 Gpr119受体调节剂和对与所述受体有关的障碍的治疗
BR112013008100A2 (pt) 2010-09-22 2016-08-09 Arena Pharm Inc "moduladores do receptor de gpr19 e o tratamento de distúrbios relacionados a eles."
WO2012135570A1 (en) 2011-04-01 2012-10-04 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
US20140066369A1 (en) 2011-04-19 2014-03-06 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
US20140051714A1 (en) 2011-04-22 2014-02-20 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
US20140038889A1 (en) 2011-04-22 2014-02-06 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
WO2012170702A1 (en) 2011-06-08 2012-12-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2013055910A1 (en) 2011-10-12 2013-04-18 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2014074668A1 (en) 2012-11-08 2014-05-15 Arena Pharmaceuticals, Inc. Modulators of gpr119 and the treatment of disorders related thereto
AU2016229982B2 (en) 2015-03-09 2020-06-18 Intekrin Therapeutics, Inc. Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy
CN109906082A (zh) 2016-09-07 2019-06-18 塔夫茨大学信托人 使用免疫dash抑制剂和pge2拮抗剂的组合治疗
EP3606527A1 (en) 2017-04-03 2020-02-12 Coherus Biosciences, Inc. Ppar-gamma agonist for treatment of progressive supranuclear palsy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2099158T3 (es) 1990-04-14 1997-05-16 New England Medical Center Inc Tratamiento del rechazo de trasplantes o de enfermedades autoinmunitarias y complejo de la formula general x-pro-y-boropro asociada al mismo.
CA2121369C (en) 1991-10-22 2003-04-29 William W. Bachovchin Inhibitors of dipeptidyl-aminopeptidase type iv
IL111785A0 (en) * 1993-12-03 1995-01-24 Ferring Bv Dp-iv inhibitors and pharmaceutical compositions containing them
TW492957B (en) * 1996-11-07 2002-07-01 Novartis Ag N-substituted 2-cyanopyrrolidnes
US5952301A (en) 1996-12-10 1999-09-14 1149336 Ontario Inc. Compositions and methods for enhancing intestinal function

Also Published As

Publication number Publication date
PL195779B1 (pl) 2007-10-31
ES2265918T3 (es) 2007-03-01
TWI244920B (en) 2005-12-11
HK1046647B (zh) 2005-09-30
CZ20013410A3 (cs) 2002-04-17
AU765912B2 (en) 2003-10-02
PT1162969E (pt) 2006-10-31
WO2000056296A3 (en) 2001-01-25
MXPA01009612A (es) 2002-07-02
EP1162969A2 (en) 2001-12-19
IL145569A0 (en) 2002-06-30
MY135683A (en) 2008-06-30
DE60028552D1 (de) 2006-07-20
EP1162969B1 (en) 2006-06-07
AR023129A1 (es) 2002-09-04
CA2366911A1 (en) 2000-09-28
CN1196483C (zh) 2005-04-13
CN1352557A (zh) 2002-06-05
GB9906714D0 (en) 1999-05-19
RU2246944C2 (ru) 2005-02-27
TR200102647T2 (tr) 2002-01-21
DE60028552T2 (de) 2007-06-28
KR100689951B1 (ko) 2007-03-08
PL350797A1 (en) 2003-02-10
CA2366911C (en) 2010-01-19
HUP0200410A3 (en) 2002-09-30
KR20010108388A (ko) 2001-12-07
ZA200108083B (en) 2002-11-27
HK1046647A1 (en) 2003-01-24
AU3317700A (en) 2000-10-09
JP2002539243A (ja) 2002-11-19
US7115650B1 (en) 2006-10-03
NZ514449A (en) 2002-11-26
NO20014607D0 (no) 2001-09-21
WO2000056296A2 (en) 2000-09-28
NO20014607L (no) 2001-11-20
HUP0200410A2 (en) 2002-08-28
DK1162969T3 (da) 2006-09-18
ATE328594T1 (de) 2006-06-15

Similar Documents

Publication Publication Date Title
UA77644C2 (en) Use of inhibitors of dipeptidyl peptidase iv in treatment of infertility
UA73115C2 (en) Use of dipeptidyl peptidase iv inhibitors for treating short stature due to growth hormone deficiency
KR102368948B1 (ko) Kras 저해 작용을 갖는 환상 펩티드 화합물
HK1089749A1 (en) Use of a pharmaceutical composition containing a para-aminophenyl acetic acid derivative for treating inflammatory conditions of the gastrointestinal tract
NO982731L (no) Antagonister av gonadotropinfrigivende hormon
HUT72436A (en) Process for the production of imidazopyridines and pharmaceutical compositions containing them and which are suitable for treating gastro-intestinal diseases
MXPA04000338A (es) Diamindioles para tratamiento de enfermedad de alzheimer.
RU95110937A (ru) Хинолоновые и акридиноновые соединения, способ их получения, фармацевтическая композиция и промежуточные соединения
KR20010080564A (ko) 사이클로알킬 치환 아미노메틸피롤리딘 유도체
MXPA04000337A (es) Amindioles para tratamiento de enfermedad de alzheimer.
ES8307778A1 (es) Procedimiento para preparar difenilbutil-1-piperazinocarboxilatos.
UA61056C2 (en) Componuds with properties of growth hormone release, as pharmaceutical composition, a method for stimulating the growth hormone release from the pituitary and a method for increasing animal growth rate